BrightSpring Health Services, Inc. (BTSG) Q1 2024 Earnings Call Transcript

BrightSpring Health Services, Inc. (NASDAQ:BTSG) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Jennifer Phipps – Chief Accounting OfficerJon Rousseau – President and CEOJim Mattingly – CFO Conference Call Participants Jamie Perse – Goldman SachsBrian Tanquilut – JefferiesLinda Bolduc – Morgan StanleyWhit Mayo – Leerink PartnersUnidentified Analyst – Bank of…

Read More

Syra Health Corp. (SYRA) Q4 2023 Earnings Call Transcript

Syra Health Corp. (NASDAQ:SYRA) Q4 2023 Earnings Call Transcript March 25, 2024 9:00 AM ET Company Participants Ben Shamsian – IRDeepika Vuppalanchi – CEOSandeep Allam – Executive Chairman and PresidentPriya Prasad – CFO Operator Good morning, ladies and gentlemen, and welcome to Syra Health Fourth Quarter and Full Year 2023 Financial Results Conference Call. At…

Read More

SANUWAVE Health Inc. (SNWV) Q4 2023 Earnings Call Transcript

SANUWAVE Health Inc. (OTCQB:SNWV) Q4 2023 Results Conference Call March 22, 2024 8:30 AM ET Company Participants Morgan Frank – CEO & ChairmanToni Rinow – Chief Financial Officer Conference Call Participants Candace Laryea – MD Catastrophic Care Consultants Operator Good day, and welcome to SANUWAVE’s Fourth Quarter Results Conference Call. [Operator Instructions] Please note, today’s…

Read More

Phibro Animal Health Corporation (PAHC) Q2 2024 Earnings Call Transcript

Phibro Animal Health Corporation (NASDAQ:PAHC) Q2 2024 Earnings Conference Call February 8, 2024 9:00 AM ET Company Participants Richard Johnson – Chief Financial Officer Jack Bendheim – Chairman, President and Chief Executive Officer Daniel Bendheim – Executive Vice President, Corporate Strategy Glenn David – Incoming Chief Financial Officer Conference Call Participants Erin Wright – Morgan…

Read More

Navigating Day One Biopharmaceuticals’ Financial Health And Clinical Prospects

FatCamera/E+ via Getty Images Amid the volatile terrain that is biopharmaceuticals, Day One Biopharmaceuticals (NASDAQ:DAWN) is a leader when it comes to pediatric oncology. Day One, through its lead candidate, tovorafenib, has positioned itself as a player committed to addressing the unmet needs of pediatric cancer patients, and it has been progressing through clinical trials…

Read More

Elevance Health Q4: Undervalued Despite Risks To Core Business (NYSE:ELV)

mediaphotos Elevance Health, Inc. (NYSE:ELV) reported earnings on January 24th with a favorable reception. Elevance Health is the largest commercial insurance company in the United States. Its comprehensive business model centers on ‘whole health’. Elevance Health’s services extend across various domains of healthcare. These include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans…

Read More

CVS Health: Back In The Buy Column (NYSE:CVS)

Bloomberg/Bloomberg via Getty Images This article was co-produced with Chuck Walston. Although I characterize myself as a largely buy-and-hold investor, I’ll admit I kicked CVS Health Corporation (NYSE:CVS) stock to the curb when the company froze its dividend. I did this even though I understood the logic behind management’s decision. Back in 2017, CVS made…

Read More

Cooper: Women Health Business Make Room For Growth; Path For Margin Expansion (NASDAQ:COO)

BlackJack3D The Cooper Companies (NASDAQ:COO) has been quite successful in their core contact lens industry, experiencing high-single-digit growth. The company has been expanding into the women’s health business, with the CooperSurgical business mix increasing from 17% a decade ago to 32% of total revenue today. I believe their strategic business expansion makes sense, and they…

Read More

Teladoc Health, Inc. (TDOC) CEO Jason Gorevic Presents at 42nd Annual JPMorgan Healthcare Conference Transcript

Teladoc Health, Inc. (NYSE:TDOC) 42nd Annual JPMorgan Healthcare Conference January 9, 2024 4:30 PM ET Company Participants Jason Gorevic – CEO Conference Call Participants Lisa Gill – JPMorgan Lisa Gill Good afternoon. My name is Lisa Gill, and I am the Head of Healthcare Services at JPMorgan. With me this afternoon, I have Teladoc Health….

Read More

Universal Health Realty Stock: Fairly Valued And Low Dividend Coverage (NYSE:UHT)

pastorscott/E+ via Getty Images Universal Health Realty Income Trust (NYSE:UHT), founded in 1986 and headquartered in King of Prussia, PA, is a healthcare REIT that invests in and leases healthcare and human service related facilities, such as medical/office buildings, acute care hospitals, behavioral healthcare hospitals, specialty facilities, free-standing emergency departments, and childcare centers. Its portfolio…

Read More

Cardinal Health Is Setting Up For A Great 2024 (NYSE:CAH)

B4LLS Cardinal Health (NYSE:CAH), a global healthcare services and products company, operates with a diversified business model that covers pharmaceutical distribution and medical products. With operations in over 40 countries, it sources, purchases, warehouses, and distributes pharmaceutical products to pharmacies, hospitals, clinics, and other healthcare facilities. Additionally, it manufactures and distributes medical and laboratory products…

Read More

CVS Health: Risk/Reward Highly Skewed To The Upside (NYSE:CVS)

LPETTET Company Overview CVS Health Corporation (NYSE:CVS) is a US-based integrated provider of healthcare solutions across the value chain from pharmacies and primary care to health insurance for commercial and governmental customers. It is the second largest healthcare services provider in the US behind UnitedHealthcare with more than 300k employees and $322bn in revenue as…

Read More

CVS Health: Play The Long Game (NYSE:CVS)

jetcityimage Over the past two years, CVS Health Corporation (NYSE:CVS) investors have experienced ~33% top-to-trough drawdown. A raft of recent commentary from S.A. readers indicate a general aversion to the stock and disdain for the management team. On the other hand, I’ve owned CVS shares for about five years now. Sure, I would have preferred…

Read More

Aspira Women’s Health Inc. (AWH) Q3 2023 Earnings Call Transcript

Aspira Women’s Health Inc. (NASDAQ:AWH) Q3 2023 Earnings Call November 13, 2023 4:30 PM ET Company Participants Nicole Sandford – President and Chief Executive Officer Torsten Hombeck – Chief Financial Officer Conference Call Participants Ben Haynor – Alliance Global Partners Operator Good afternoon, ladies and gentlemen, and welcome to the Aspira Women’s Health Incorporated Third…

Read More

LifeStance Health Group, Inc. (LFST) Q3 2023 Earnings Call Transcript

LifeStance Health Group, Inc. (NASDAQ:LFST) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET Company Participants Monica Prokocki – Vice President, Investor Relations Ken Burdick – Chief Executive Officer Dave Bourdon – Chief Financial Officer Danish Qureshi – Chief Operating Officer Conference Call Participants Craig Hettenbach – Morgan Stanley Lisa Gill – JP…

Read More

Clover Health Investments: Improving Fundamentals Inspires Bullish Outlook (CLOV)

All_About_Najmi Investment Thesis Clover Health Investments, Corp.(NASDAQ:CLOV) has been on a transformative journey characterized by profitability objectives. I am thrilled by the company’s improving fundamentals, leading me to a long-term bullish stance. Its financial performance has been improving on a quarterly basis, which I believe reflects on its commitment to profitability objective. Given the company’s…

Read More

Evolent Health, Inc. (EVH) Q3 2023 Earnings Call Transcript

Evolent Health, Inc. (NYSE:EVH) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Seth Frank – Vice President, Investor Relations Seth Blackley – Chief Executive Officer, Co-Founder & Board Member John Johnson – Chief Financial Officer Conference Call Participants Ryan Daniels – William Blair Kevin Caliendo – UBS Unknown speaker –…

Read More

CVS Health: A Bargain Long-Term Opportunity (NYSE:CVS)

JHVEPhoto Investment Thesis Over the past five years, the shares of CVS Health Corporation (NYSE:CVS) have not changed much. I believe this is not likely to last long as valuation suggests that the shares are considerably undervalued amid present risks and offer a great upside and seemingly limited downside potential. YCharts Corporate profile CVS Health…

Read More

Sell Keurig Dr Pepper: Americans’ Health Is A Priority (NASDAQ:KDP)

Bega9000/iStock Editorial via Getty Images Cost inflation and immense competition Keurig Dr Pepper (NASDAQ:KDP) has been significantly impacted by supply chain disruptions leading to higher input costs, logistics and manufacturing and labor costs. This is partially due to geopolitical uncertainty and its impact on commodity and energy prices. We believe that the current headwinds are…

Read More